Anti-infection drug dosing in critically ill patients on ECMO
Part of Infections clinical trials.
This study looks at how anti-infection drugs work in critically ill patients who are on ECMO, a machine that helps the heart and lungs. The goal is to find the right doses so the drugs work better and are safer for people in this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your family member must sign a consent form agreeing to participate.
- You must be receiving ECMO (a machine that helps your heart and lungs work) or be a candidate for it.
- You must have an infection that needs treatment with antibiotics or other anti-infection medications.
- You must be 18 years old or older and not pregnant.
- Your medical records about antibiotics and ECMO support must be complete.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain antibiotics behave in your body when you are on VA-ECMO. The goal is to find the right dose to treat your infection effectively and safely.
This trial looks at whether and when a heart-lung machine called ECMO should be used in children whose septic shock is not responding to standard treatment. It may help doctors choose the best timing to improve survival and recovery in the PICU.
This trial is for people with severe lung failure (ARDS) who are already on a life-support machine called VV-ECMO. It tests whether adding a special breathing tube (CPAP) can help their lungs heal better.
This trial studies how to give the right dose of common antibiotics to children on ECMO (a heart-lung bypass machine). The goal is to help doctors choose the best dose to fight infections while keeping the child safe.
This trial tests whether adding an inhaled antibiotic (amikacin) to standard IV antibiotics can better treat a serious lung infection (pneumonia caused by Gram-negative bacteria) in patients on a heart-lung machine (ECMO) and a breathing tube. If you or your loved one is on ECMO and has this type of pneumonia, this study may offer a new treatment approach.
This study looks at how a medicine called L-AmB (a type of amphotericin B, used to treat fungal infections) works in patients who are on ECMO. The goal is to find the right dose for people in your situation.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.